Sub-study request for DTMP

Sub-Study - Defining and Targeting Molecular Pathways (1).docx

Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD)

Sub-study request for DTMP

OMB: 0925-0740

Document [docx]
Download: docx | pdf

Request for Approval under the Generic Clearance for the “Conference, Meeting, Workshop, and Poster Session Registration Generic Clearance (OD)”

(OMB#: 0925-0740, Expiration Date: 07/31/2022)


Shape1

TITLE OF INFORMATION COLLECTION: Defining and Targeting Molecular Pathways to Direct Personalized Value-added Treatments for Patients with Epithelial Ovarian Cancer Clinical Trials Planning Meeting


PURPOSE: To develop clinical trials, based on known and emerging molecular, immunologic, and clinical characteristics, to direct clinical application of new and existing therapeutics with improved focus. The focus of the CTPM will be on the identification and prioritization of novel and existing therapeutics and combinations to target scientifically defined ovarian cancer subgroups for more precision medicine towards the personal ovarian cancer of each woman.

The Institute of Medicine in 2016 recommended that ovarian cancer research focus on therapies to address the unique biology and clinical course of ovarian cancer.  These include the development of directed molecularly-driven and immunologic treatments for ovarian cancer subtypes and identification of markers of therapeutic response and treatment resistance. The Gynecologic Cancer Steering Committee (GCSC) brainstormed opportunities in treatment of ovarian cancers and surveyed members to prioritize recommendations. The top priority was “Application of molecular and clinical characterization for patient treatment selection”, a topic consistent with the GCSC Strategic Priorities, the HHS Strategic Plan Goals, and the IOM recommendations.


DESCRIPTION OF RESPONDENTS:

Steering committee members and their colleagues; 55 members and 8 potential NCI staff (FTEs) will be invited


TYPE OF COLLECTION: (Check all that apply)


[ ] Abstract [ ] Application

[ X ] Registration Form [ ] Other: ______________


CERTIFICATION:


I certify the following to be true:

  1. The collection is voluntary.

  2. The collection is low-burden for respondents and low-cost for the Federal Government.

  3. The collection is non-controversial and does not raise issues of concern to other federal agencies.



Name: Annette Mitchell



To assist review, please provide answers to the following question:

Personally Identifiable Information:

  1. Is personally identifiable information (PII) collected? [ X ] Yes [ ] No

  2. If Yes, is the information that will be collected included in records that are subject to the Privacy Act of 1974? [ X ] Yes [ ] No


Gifts or Payments:

Is an incentive (e.g., money or reimbursement of expenses, token of appreciation) provided to participants? [ ] Yes [X ] No


Amount: _________


Explanation for incentive: (include number of visits, etc)


ESTIMATED BURDEN HOURS and COSTS

Category of Respondent

No. of Respondents

No. of Responses per Respondent

Time per Response

(in hours)

Total Burden

Hours

Individuals

55

1

5/60

5

Totals


55


5



Category of Respondent

Total Burden

Hours

Hourly Wage Rate*

Total Burden Cost

Individuals

5

$46.95

$ 234.75

Total



$ 234.75

*Source of the mean Hourly Wage Rate is provided by the Bureau of Labor Statistics, Occupation title “Medical Scientists” 19-1040, https://www.bls.gov/oes/2019/May/oes_nat.htm#00-0000.


FEDERAL COST: The estimated annual cost to the Federal government is $8,598.06.


Staff

Grade/Step

Salary**

% of Effort

Fringe

(if applicable)

Total Cost to Gov’t

Federal Oversight






Program Director

14/6

$141,534

5%


$7076.70

Contractor Cost





$1521.36

Travel






Other Cost






Total





$8,598.06

**The salary in the table above is cited from https://www.opm.gov/policy-data-oversight/pay-leave/salaries-wages/salary-tables/20Tables/html/DCB.aspx



If you are conducting a focus group, survey, or plan to employ statistical methods, please provide answers to the following questions: N/A


The selection of your targeted respondents

Do you have a customer list or something similar that defines the universe of potential respondents and do you have a sampling plan for selecting from this universe? [x] Yes [ ] No



If the answer is yes, please provide a description of both below (or attach the sampling plan)? If the answer is no, please provide a description of how you plan to identify your potential group of respondents and how you will select them?


There is a list of steering committee members and government members that we use to invite to the registration site.


Administration of the Instrument

How will you collect the information? (Check all that apply)

[X ] Web-based or other forms of Social Media

[ ] Telephone

[ ] In-person

[ ] Mail

[ ] Survey Form

[ ] Chart Abstraction

[ ] Other, Explain


Will interviewers,facilitators, or research coordinators be used? [X ] Yes [] No


Please make sure that all instruments, instructions, and scripts are submitted with the request.



6

File Typeapplication/vnd.openxmlformats-officedocument.wordprocessingml.document
File TitleGeneric Clearance Submission Template
SubjectGeneric Clearance Submission Template
AuthorMorales, Sussana (NIH/NCI) [E]
File Modified0000-00-00
File Created2022-02-01

© 2024 OMB.report | Privacy Policy